Raymond James Trust N.A. Organon & Co. Transaction History
Raymond James Trust N.A.
- $4.22 Billion
- Q2 2024
A detailed history of Raymond James Trust N.A. transactions in Organon & Co. stock. As of the latest transaction made, Raymond James Trust N.A. holds 15,495 shares of OGN stock, worth $309,435. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,495
Previous 16,307
4.98%
Holding current value
$309,435
Previous $306,000
4.58%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding OGN
# of Institutions
795Shares Held
191MCall Options Held
1.59MPut Options Held
931K-
Black Rock Inc. New York, NY32.6MShares$651 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.2MShares$603 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.1MShares$202 Million0.07% of portfolio
-
State Street Corp Boston, MA9.01MShares$180 Million0.01% of portfolio
-
Nordea Investment Management Ab Stockholm, V77.43MShares$148 Million0.19% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $5.08B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...